IDiyas

For the Inventor, By the Inventor

Beijing, China

Yaode Wang

USPTO Granted Patents = 10 

 

 

Average Co-Inventor Count = 9.8

ph-index = 3

Forward Citations = 26(Granted Patents)


Company Filing History:

goldMedal7 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
silverMedal4 out of 18 
 
Alectos Therapeutics Inc.
 patents
bronzeMedal1 out of 1 
 
Xrad Therapeutics, Inc.
 patent
4. 1 out of 4 
 
Anima Biotech Inc.
 patents
5. 1 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):
1. 12404283 - c-MYC mRNA translation modulators and uses thereof in the treatment of cancer (2025-09-02),
2. 12187742 - Dual ATM and DNA-PK inhibitors for use in anti-tumor therapy (2025-01-07),
3. 10022461 - Pyrrolo[2,3-C]pyridines as imaging agents for neurofibrilary tangles (2018-07-17),
4. 9938299 - Glycosidase inhibitors and uses thereof (2018-04-10),
5. 9815861 - Selective glycosidase inhibitors and uses thereof (2017-11-14),
6. 9808542 - Pyrrolo[2,3-C]pyridines as imaging agents for neurofibrillary (2017-11-07),
7. 9718854 - Selective glycosidase inhibitors and uses thereof (2017-08-01),
8. 9611275 - Permeable glycosidase inhibitors and uses thereof (2017-04-04),
9. 8933040 - Selective glycosidase inhibitors and uses thereof (2015-01-13),
10. 8901087 - Selective glycosidase inhibitors and uses thereof (2014-12-02),

Title: The Innovative Contributions of Yaode Wang

Introduction

Yaode Wang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel therapeutic agents. With a total of 10 patents to his name, Wang's work has the potential to impact the lives of many patients suffering from oncologic diseases.

Latest Patents

Wang's latest patents include groundbreaking inventions such as c-MYC mRNA translation modulators and their uses in the treatment of cancer. This invention relates to novel c-MYC mRNA translation modulators, compositions, and methods of preparation, which are aimed at improving cancer treatment outcomes. Another notable patent is for dual ATM and DNA-PK inhibitors for use in anti-tumor therapy. This patent provides compounds that are useful for the treatment of oncologic diseases, along with their pharmaceutically acceptable salts.

Career Highlights

Throughout his career, Yaode Wang has worked with leading companies in the pharmaceutical industry, including Merck Sharp & Dohme Corporation and Alectos Therapeutics Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in cancer therapies.

Collaborations

Wang has collaborated with esteemed colleagues such as Harold G Selnick and Zhongyong Wei. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the development of new therapeutic solutions.

Conclusion

Yaode Wang's contributions to cancer treatment through his innovative patents and collaborations highlight his dedication to improving patient outcomes. His work continues to pave the way for advancements in oncologic therapies, making a significant impact in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…